| A pilot study of pioglitazone treatment for nonalcoholic steatohepatitis K Promrat, G Lutchman, GI Uwaifo, RJ Freedman, A Soza, T Heller, E Doo, ... Hepatology 39 (1), 188-196, 2004 | 1016 | 2004 |
| Value of adenosine deaminase (ADA) in ascitic fluid for the diagnosis of tuberculous peritonitis: a meta-analysis A Riquelme, M Calvo, F Salech, S Valderrama, A Pattillo, M Arellano, ... Journal of clinical gastroenterology 40 (8), 705-710, 2006 | 383 | 2006 |
| Neutropenia during combination therapy of interferon alfa and ribavirin for chronic hepatitis C A Soza, JE Everhart, MG Ghany, E Doo, T Heller, K Promrat, Y Park, ... Hepatology 36 (5), 1273-1279, 2002 | 334 | 2002 |
| Nonalcoholic fatty liver disease in women with polycystic ovary syndrome C Cerda, RM Pérez-Ayuso, A Riquelme, A Soza, P Villaseca, ... Journal of hepatology 47 (3), 412-417, 2007 | 313 | 2007 |
| Predictors of nonalcoholic steatohepatitis (NASH) in obese patients undergoing gastric bypass C Boza, A Riquelme, L Ibañez, I Duarte, E Norero, P Viviani, A Soza, ... Obesity surgery 15 (8), 1148-1153, 2005 | 265 | 2005 |
| Non‐alcoholic fatty liver disease and its association with obesity, insulin resistance and increased serum levels of C‐reactive protein in Hispanics A Riquelme, M Arrese, A Soza, A Morales, R Baudrand, RM Pérez‐Ayuso, ... Liver international 29 (1), 82-88, 2009 | 209 | 2009 |
| Associations of chemokine system polymorphisms with clinical outcomes and treatment responses of chronic hepatitis C K Promrat, DH McDermott, CM Gonzalez, DE Kleiner, DE Koziol, M Lessie, ... Gastroenterology 124 (2), 352-360, 2003 | 170 | 2003 |
| Maintenance therapy with ribavirin in patients with chronic hepatitis C who fail to respond to combination therapy with interferon alfa and ribavirin JH Hoofnagle, MG Ghany, DE Kleiner, E Doo, T Heller, K Promrat, J Ong, ... Hepatology 38 (1), 66-74, 2003 | 117 | 2003 |
| The liver in times of COVID-19: What hepatologists should know E Ridruejo, A Soza Annals of hepatology 19 (4), 353-358, 2020 | 116 | 2020 |
| Efficacy and safety of ombitasvir/paritaprevir/r and dasabuvir compared to IFN-containing regimens in genotype 1 HCV patients: The MALACHITE-I/II trials GJ Dore, B Conway, Y Luo, E Janczewska, B Knysz, Y Liu, ... Journal of hepatology 64 (1), 19-28, 2016 | 103 | 2016 |
| Liver transplantation for hepatocellular carcinoma: evaluation of the alpha‐fetoprotein model in a multicenter cohort from Latin America F Piñero, M Tisi Baña, EC de Ataide, S Hoyos Duque, S Marciano, ... Liver International 36 (11), 1657-1667, 2016 | 102 | 2016 |
| Management of nonalcoholic fatty liver disease: an evidence-based clinical practice review JP Arab, R Candia, R Zapata, C Muñoz, JP Arancibia, J Poniachik, ... World Journal of Gastroenterology: WJG 20 (34), 12182, 2014 | 93 | 2014 |
| Platelet count/spleen diameter ratio for non-invasive prediction of high risk esophageal varices in cirrhotic patients F Barrera, A Riquelme, A Soza, Á Contreras, G Barrios, O Padilla, ... Annals of Hepatology 8 (4), 325-330, 2009 | 89 | 2009 |
| Treatment with direct‐acting antivirals for HCV decreases but does not eliminate the risk of hepatocellular carcinoma F Piñero, M Mendizabal, E Ridruejo, F Herz Wolff, B Ameigeiras, ... Liver International 39 (6), 1033-1043, 2019 | 88 | 2019 |
| Increased orocecal transit time in patients with nonalcoholic fatty liver disease A Soza, A Riquelme, R GonzÁlez, M Alvarez, RM Pérez-Ayuso, ... Digestive diseases and sciences 50, 1136-1140, 2005 | 85 | 2005 |
| Thalidomide for the treatment of metastatic hepatic epithelioid hemangioendothelioma: a case report with a long term follow-up F Salech, S Valderrama, B Nervi, JC Rodriguez, D Oksenberg, A Koch, ... Annals of hepatology 10 (1), 99-102, 2016 | 82 | 2016 |
| High prevalence of hepatic steatosis and vascular thrombosis in COVID-19: A systematic review and meta-analysis of autopsy data LA Díaz, F Idalsoaga, M Cannistra, R Candia, D Cabrera, F Barrera, ... World journal of gastroenterology 26 (48), 7693, 2020 | 80 | 2020 |
| Disease progression in patients with hepatitis C virus infection treated with direct-acting antiviral agents M Mendizabal, F Piñero, E Ridruejo, FH Wolff, M Anders, V Reggiardo, ... Clinical Gastroenterology and Hepatology 18 (11), 2554-2563. e3, 2020 | 73 | 2020 |
| Analysis of natural variants of the hepatitis C virus internal ribosome entry site reveals that primary sequence plays a key role in cap-independent translation MI Barría, A Gonzalez, J Vera-Otarola, U Leon, V Vollrath, D Marsac, ... Nucleic acids research 37 (3), 957-971, 2009 | 71 | 2009 |
| Steatotic livers. Can we use them in OLTX? Outcome data from a prospective baseline liver biopsy study M Gabrielli, F Moisan, M Vidal, I Duarte, M Jiménez, G Izquierdo, ... Annals of Hepatology 11 (6), 891-898, 2012 | 64 | 2012 |
T. Jake LiangNIHبريد إلكتروني تم التحقق منه على nih.gov
